最新报道:Litecoin surged past a 3-year consolidation phase following a $100M institutional purchase by MEI Pharma, GSR, and founder Charlie Lee, driving its price toward $130. Technical analysis indicates a retest of the $114 support-turned-resistance level and a descending wedge pattern, pointing to potential short-term and long-term targets of $147 and $296, respectively. Analysts highlight the institutional buying strategy and alignment with key moving averages, suggesting sustained momentum but warning of pullback risks if the price falls below $114.